Demo Sign up Log In

Biocryst Pharmaceuticals Inc (BCRX)

R&D Expenses

$197.76M

TTM · Period ending: Jun 30, 2026 · USD

BCRX R&D Expenses

Latest reported$197.76Mperiod endingJun 30, 2026

Latest reported$197.76Mperiod endingJun 30, 2026

BCRX TTM R&D Expenses ($0.00 → $197.76M)

TTM R&D Expenses

High-resolution chart · PNG

BCRX r&d expenses history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Biocryst Pharmaceuticals Inc R&D Expenses — Trailing twelve months (TTM) (USD)
Period ending	R&D Expenses (USD)
Jun 30, 2001	10,196,352
Mar 31, 2001	10,184,352
Dec 31, 2000	9,590,732
Sep 30, 2000	8,476,380
Jun 30, 2000	8,338,380
Mar 31, 2000	7,436,380
Dec 31, 1999	7,700,000
Sep 30, 1999	7,500,000
Jun 30, 1999	8,000,000
Mar 31, 1999	8,800,000
Dec 31, 1998	9,300,000
Sep 30, 1998	10,500,000
Jun 30, 1998	10,500,000
Mar 31, 1998	10,400,000
Dec 31, 1997	10,600,000
Sep 30, 1997	7,800,000
Jun 30, 1997	7,600,000
Mar 31, 1997	7,000,000
Dec 31, 1996	5,600,000
Sep 30, 1996	5,600,000
Jun 30, 1996	5,100,000
Mar 31, 1996	4,500,000
Dec 31, 1995	5,500,000
Sep 30, 1995	5,500,000
Jun 30, 1995	3,800,000
Mar 31, 1995	2,500,000
Dec 31, 1994	0

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.